Moreover, treatment of cells with RAD001, a novel mTOR inhibitor, resulted in low mTOR phosphorylation and suppressed the cell proliferation of progestin-resistant endometrial cancer cells by activating autophagy. Here, MTOR is linked to endometrial cancer.